Spring direct naar de hoofdnavigatie of de inhoud
‘An adequate IP strategy protects innovation and creates new chances’
Marthe Lindenbergh

Marthe Lindenbergh

  • Life Sciences
  • Trainee Patent Attorney

Marthe Lindenbergh obtained a Bachelor’s and Master’s degree in Biomedical Sciences at Utrecht University. During the Master-phase, she did research internships in the UMC Utrecht and at the University of California, San Francisco. Having specialized in Infection and Immunity, she continued her studies with a PhD track at Utrecht University and the Wilhelmina Children’s Hospital, where she studied the immune-modulatory functions of immune-cell-derived extracellular vesicles. In 2019 she started as a trainee patent attorney at V.O. She obtained her PhD in November 2019.

Continue reading

Working experience

  • Trainee Patent Attorney V.O. (2019-present)
  • PhD University of Utrecht (2014-2018)

Education

  • PhD Infection and Immunity, University of Utrecht (2019)
  • MSc Infection and Immunity, University ofUtrecht (2014)
  • BSc Biomedical Sciences , University of Utrecht (2012)

Publications

  • M. Mues, L. Karra, D. Romero-Moya, A. Wandler, M. J. Hangauer, O. Ksionda, Y. Thus, M.F.S. Lindenbergh, K. Shannon, M. T. McManus, J. P. Roose. “High-complexity shRNA libraries and PI3 kinase inhibition in cancer: high-fidelity synthetic lethality predictions”. Cell Reports 2019
  • M.F.S. Lindenbergh, D.G.J. Koerhuis, E.G.F. Borg, E.M. van ’t Veld, T.A.P. Driedonks, R. Wubbolts, W. Stoorvogel, M. Boes. “Bystander T-cells support clonal T-cell activation by controlling the release of dendritic cell-derived immune-stimulatory extracellular vesicles”. Front. Imm. 2019
  • M.F.S. Lindenbergh, W. Stoorvogel. “Antigen presentation by extracellular vesicles from professional antigen-presenting cells”.  Annu. Rev. Immunol. 2018
  • A.M. Gram, T. Oosenbrug, M.F.S. Lindenbergh, C. Büll, A. Comvalius, K.J.I. Dickson, J. Wiegant, H. Vrolijk, R.J. Lebbink, R. Wolterbeek, G.J. Adema, M. Griffioen, M.H.M. Heemskerk, D.C. Tscharke, L. M. Hutt-Fletcher, E.J.H.J. Wiertz, R.C. Hoeben, M.E. Ressing. “The Epstein-Barr virus glycoprotein gp150 forms an immune-evasive glycan shield at the surface of infected cells”. PLoS Path. 2016
  • M. van Gent, A.M. Gram, I.G.J. Boer, R.J. Geerdink, M.F.S. Lindenbergh, R.J. Lebbink, E.J. Wiertz, M.E. Ressing. “Silencing the shutoff protein of Epstein-Barr virus in productively infected B cells points to (innate) targets for immune evasion”.  J. Gen. Virol. 2015.

Languages

  • Dutch
  • English

Also see these experts

Mark Einerhand

Mark Einerhand

  • European and Dutch Patent Attorney
  • Partner
Tamara Elmore

Tamara Elmore

  • European and Dutch Patent Attorney
  • United States Patent Agent
  • Partner
More experts

News

Highly rated by IP Stars 2021

IP Stars has rated V.O. highly for its expertise and performance in 2021. Formerly known as Managing IP, this leading guide to IP firms has published annual rankings since 1989, listing the top IP firms worldwide by category.Continue reading

COVID-19 update 10

The government measures to combat COVID-19 not only affect business operations but they could also impact you as a patent applicant or patent holder.Continue reading

How can knowledge institutions and companies make the best use of their IP?

Both knowledge institutions and companies are often uncertain about how to successfully secure and exploit intellectual property (IP), what legal steps are required and who can provide assistance.Continue reading

Events

Scale up digital – grow your business

Amsterdam Science Park, Science Park, Amsterdam

Growth is not easy to achieve. Especially not on your own, because you are busy with your daily business. Continue reading

Dutch Lifes Sciences Conference 2021

CORPUS Congress Centre, Willem Einthovenstraat, Oegstgeest, Netherlands

The foremost life sciences business network event in the Netherlands. Continue reading